Adverse Effects of Alfentanil versus Nalbuphine in Decompensated Cirrhotic Patients Undergoing Painless Gastroscopy: A Double-Blind, Randomized Controlled Trial
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s540089 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Xiao-Yu Gu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, NO.215 Hospital of Shaanxi Nuclear Industry, Xianyang, People's Republic of China. Hauptthemen laut MEDLINE: Alfentanil, Analgesics, Opioid, Gastroscopy, Liver Cirrhosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, NO.215 Hospital of Shaanxi Nuclear Industry, Xianyang, People's Republic of China.
ORCID-Profile: Xiao-Yu Gu
Zitieren
APA
Gu, X. Y., Cao, J. F., Zhang, X. Y., Cheng, Y., & Jiang, L. Q. (2025). Adverse Effects of Alfentanil versus Nalbuphine in Decompensated Cirrhotic Patients Undergoing Painless Gastroscopy: A Double-Blind, Randomized Controlled Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s540089
Vancouver
Gu XY, Cao JF, Zhang XY, Cheng Y, Jiang LQ. Adverse Effects of Alfentanil versus Nalbuphine in Decompensated Cirrhotic Patients Undergoing Painless Gastroscopy: A Double-Blind, Randomized Controlled Trial. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s540089
BibTeX
@article{Gu2025,
author = {Gu, Xiao-Yu and Cao, Jin-Feng and Zhang, Xin-Yang and Cheng, Yao and Jiang, Liu-Qin},
title = {Adverse Effects of Alfentanil versus Nalbuphine in Decompensated Cirrhotic Patients Undergoing Painless Gastroscopy: A Double-Blind, Randomized Controlled Trial},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s540089}
}
EUVIMED